F.D.A. Looks to A.I. to Enhance Efficiency

F.D.A. Looks to A.I. to Enhance Efficiency

The Food and Drug Administration is planning to use artificial intelligence to “radically increase efficiency” in deciding whether to approve new drugs and devices, one of several top priorities laid out in an article published Tuesday in JAMA. Another initiative involves a review of chemicals and other “concerning ingredients” that appear in U.S. food but…

Read More
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use. The decision means many Americans without underlying conditions may not have access to…

Read More
FDA to revisit approval of

FDA to revisit approval of

The Food and Drug Administration is planning to revisit its approval of the food additive ADA, the agency’s top foods official announced Thursday, after longstanding questions over the safety of the so-called “yoga mat” chemical that can be a bread ingredient in the U.S. but is banned in Europe.  Also called azodicarbonamide, the FDA previously…

Read More
Cinnamon supplements might pose risks for people on anticoagulant medication: Research  | The Express Tribune

Cinnamon supplements might pose risks for people on anticoagulant medication: Research | The Express Tribune

Listen to article Cinnamon may be a beloved spice in kitchens and health stores alike, but a new study has found that overconsumption could interfere with how the body processes prescription drugs. Published in the journal Food Chemistry: Molecular Sciences, the study found that cinnamaldehyde – the active compound in cinnamon – is highly bioaccessible and may…

Read More
FDA’s top inspector abruptly retires

FDA’s top inspector abruptly retires

The Food and Drug Administration’s top official overseeing drug and food safety inspections told staff on Monday he has decided to leave the agency, and multiple federal health officials told CBS News it comes amid frustration from inspectors with the FDA’s new commissioner. Michael Rogers had worked for the FDA for more than three decades,…

Read More